SecuringPharma - Pharmaceutical anti-counterfeiting news

News headlines:

Manage subscription Reset Password

EC seeks comment on GMP for active substances

The EC has published its latest concept paper designed to invite comment on the implementation of last year’s falsified medicines directive, this time looking at GMP for active substances.

Other News

Discovery of miltefosine fakes highlights need for simple assays
The discovery of counterfeit generic miltefosine capsules for the treatment of visceral leishmaniasis serves to underscore the urgent need for simple, inexpensive assays to evaluate medicines quality in the field.
Pakistan shuts down pharma facility after deaths
The authorities in Pakistan have shut down a manufacturing facility in Punjab on suspicion of producing substandard and potentially spurious medicines that have killed dozens of people, according to local news reports.
US generic drug user fee proposals mean more facilities inspections
Manufacturers of APIs and finished dosage forms destined for the US market will be subject to more frequent inspections if Congress adopts the FDA's proposals for a new a Generic Drug User Fee Act.
Counterfeit antimalarials in Africa on the rise, caution scientists
Researchers are recommending "multiple parallel strategies" to stave off an alarming rise in fake and substandard antimalarials in Africa.
Pharma cargo thefts decline in 2011
The number of thefts of pharmaceutical shipments declined significantly in 2011, with fewer cases and a much lower average value per incident, according to data compiled by security firm Freightwatch.
US counterfeit drug seizures up 200 per cent in 2011
Seizures of counterfeit pharmaceuticals by US customs almost tripled in 2011 compared to the previous year, thanks in part to greater enforcement activity. The value of goods seized rose by $11m to reach $16.8m.

News in brief

EC seeks comment on unique medicine identifiers
The European Commission has published a concept paper on the unique identifier for medicines, outlined in the EU falsified medicines directive and due to be fleshed out via the delegated acts process.
WHO working group drafts resolution on SSFFC medicines
Last week's meeting of a WHO working group on low quality and illegal drugs ended with a draft resolution for debate at the next World Health Assembly.
FDA finalises guidance for on-dose anti-counterfeit technologies
The US FDA has published its final guidance on the use of on-dose anti-counterfeiting technologies - referred to as physicochemical identifiers or PCIDs - for use in solid oral dosage forms such as tablets and capsules.
Pangea IV nets illegal medicines worth around $6.3m
The latest Interpol-backed offensive against illegal medicines has led to 55 arrests and seizures of 2.4m potentially harmful drugs worth around $6.3m.
FDA report models counterfeiting and diversion patterns in US
A new report form the US Food and Drug Administration (FDA) has used historical cases of medicine counterfeiting and diversion to gain a better understanding of the methods used by criminals and help prevent incidents in future.